Latest News and Press Releases
Want to stay updated on the latest news?
-
Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- Tumor infiltrating lymphocyte (TIL) therapy is an emerging field in cancer immunotherapy. As researchers all over the world are conducting clinical trials...
-
DELHI, India, Oct. 22, 2020 (GLOBE NEWSWIRE) -- "Global Tumor Infiltrating Lymphocytes Immunotherapy Market Opportunity & Clinical Trials Insight 2025" Report Highlights: Tumor Infiltrating...